Newly approved medicinal products
13.12.2010
Here you can find a list of newly approved medicinal products between 1st November 2010 and 30th November 2010.
more
News and Educations
Opening ceremony for the Twinning Light Project "Strengthening of expert capacity in implementation of EU legislation on medicines in the Croatian Agency for Medicinal Products and Medical Devices"
10.12.2010
The opening ceremony for the Twinning Light Project "Strengthening of expert capacity in implementation of EU legislation on medicines in the Croatian Agency for Medicinal Products and Medical Devices", organised by the Croatian Agency for Medicinal Products and Medical Devices (HALMED) and the Delegation of the European Union to the Republic of Croatia was held on Friday, 10 December 2010 in the Palace Hotel Zagreb.
This project with a budget of € 250,000 is financed by the European Union and its activities will be implemented over a 6 months period. Member State Twinning Partner is Spanish Agency for Medicines and Medical Devices (Agencia Española de Medicamentos y Productos Sanitarios, AEMPS).
more
Newly approved medicinal products
10.11.2010
Here you can find a list of newly approved medicinal products between 1st October 2010 and 31st October 2010.
more
Newly approved medicinal products
11.10.2010
Here you can find a list of newly approved medicinal products between 1st September 2010 and 30th September 2010.
more
Newly approved medicinal products
13.09.2010
Here you can find a list of newly approved medicinal products between 1st August 2010 and 31st August 2010.
more
Newly approved medicinal products
19.08.2010
Here you can find a list of newly approved medicinal products between 1st July 2010 and 31st July 2010.
more
Newly approved medicinal products
12.07.2010
Here you can find a list of newly approved medicinal products between 1st June 2010 and 30th June 2010.
more
Newly approved medicinal products
11.06.2010
Here you can find a list of newly approved medicinal products between 1st May 2010 and 31st May 2010.
more
Important notice concerning safety of medicinal products containing the active substance bufexamac with recommendations for physicians, pharmacists and patients
01.06.2010
The European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended revocation of marketing authorisation for all medicinal products containing the active ingredient bufexamac. Based on the CHMP's opinion, the European Commission will issue final recommendations for the medicinal products containing the aforementioned active substance.
The Agency for Medicinal Products and Medical Devices (HALMED) initiated the review process for the EMA's recommendation, issuing the recommendations for physicians, pharmacists and patients.
more
Notice concerning the shorter shelf-life of Act-HIB, vaccine against Haemophilus influenzae type B, Vaccinum haemophili stirpe b coniugatum, Lot D0636-3
01.06.2010
In collaboration with the Agency for Medicinal Products and Medical Devices, on 31 May 2010, Medoka d.o.o. sent a notice to the Croatian National Institute of Public Health, all County Institutes of Public Health, Institute of Immunology (warehousing and distribution of vaccines from the Vaccination Programme) and vaccinators, advising them of the shorter shelf life of Act-HIB, vaccine against Haemophilus influenzae type b, Lot: D0636-3.
more
